In a groundbreaking initiative, the National Institutes of Health (NIH) is spearheading a workshop titled “Artificial Intelligence in Precision Medicine for Diabetes and Other Chronic Diseases.” This event is set to explore the transformative potential of artificial intelligence (AI) and machine learning (ML) in advancing precision medicine, particularly for diabetes and chronic diseases.

The workshop seeks to unite biomedical researchers and AI/ML experts to tackle pressing challenges, identify crosscutting gaps, and seize opportunities in leveraging AI/ML technologies. The focus is on enhancing biomarker development, drug discovery, and diagnostics, ultimately paving the way for personalized healthcare solutions. Recent strides in AI/ML, including generative AI and Large Language Models, are poised to revolutionize biomedicine.

Organizing Committee
The event is organized by a distinguished committee, featuring external co-chairs such as Marcela Brissova from Vanderbilt University, Jeffrey Grethe from the University of California, San Diego, and Wei Wang from the University of California, Los Angeles. They are joined by notable members from the NIH, including Eric Brunskill, Ph.D., and Debbie Gipson, M.D., M.S.

Pre-workshop Speaker Series
A pre-workshop speaker series has been designed to stimulate discussions on AI’s intersection with biomedicine. The series is divided into two parts:

  1. The Bio-Behavioral Dimensions of Diabetes Heterogeneity: Featuring Dr. Yao Qin from the University of California, Santa Barbara, discussing “Data-driven Machine Learning and Closed-loop Diabetes Care,” and Dr. Ashu Sabharwal from Rice University on “Bio-behavioral Pathways in Diabetes.”
  2. Advances in AI and Applications in Biomedicine: Featuring Dr. James Zou from Stanford University, focusing on “AI Agents in Biomedicine,” and Dr. Eran Halperin from the University of California, Los Angeles, discussing “AI Challenges and Opportunities across Data Modalities in Medicine.”
Event Details
The workshop is a hybrid event, allowing both in-person and virtual participation. It will be held at the Neuroscience Center Building in Rockville, MD. Although registration closed on October 25, 2024, the event promises to be a pivotal moment in the integration of AI/ML in precision medicine.

For more information, interested parties can access the original article and additional resources such as the Pre-Workshop Webinar 1 Flyer and Pre-Workshop Webinar 2 Flyer.

Contact Information

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Revolutionizing Clinical Care: The Age of Genome Sequencing

Genome sequencing is taking center stage, reshaping how we approach the diagnosis and treatment of genetic conditions.

By |January 9, 2025|Categories: Article, Genomics, Healthcare|Tags: , |0 Comments

The Future of Health-Tech in 2025

The global market is projected to surpass $200 billion, expanding at a compound annual growth rate (CAGR) of 25%. Predictive and personalized healthcare will see significant advancements in 2025.

Unveiling Flood Adaptation Disparities in the USA

In a groundbreaking analysis published in Nature, researchers have shone a light on the stark disparities in flood adaptation across the United States, exposing significant differences in how communities access and benefit from flood adaptation measures.

Ethereum’s Serenity Upgrade Sparks Excitement and Market Optimism

Ethereum has shifted to a fully proof-of-stake consensus mechanism, drastically cutting down on the energy typically required for network maintenance.

By |January 8, 2025|Categories: Article, Cryptocurrency, Technology|Tags: , |0 Comments

AI Outperforms Human Experts in Ovarian Cancer Detection

In a groundbreaking study led by researchers at the Karolinska Institutet in Sweden, artificial intelligence (AI) has demonstrated a remarkable ability to detect ovarian cancer, surpassing the accuracy of human doctors.

By |January 8, 2025|Categories: Article, Health, Technology|Tags: , |0 Comments